A study of hepatitis A virus seropositivity among children aged between 1 and 5 years of age: Implications for

Rakesh Gupta1, R K Sanjeev2, A Agarwal3

  • 1Director, Government Institute of Medical Sciences, Greater Noida, Gautam Buddha Nagar 201310, India.

Insights

Hepatitis A virus (HAV) seroprevalence was 43.5% in Indian children under five. Younger children showed lower seroprevalence, indicating susceptibility and a need for vaccination and improved public health measures.

Area of Science:

  • * Infectious Diseases
  • * Pediatrics
  • * Public Health

Background:

  • * Hepatitis A virus (HAV) is an enterically transmitted viral disease prevalent in developing countries, primarily affecting children.
  • * An epidemiological shift indicates an increasing incidence of symptomatic HAV cases in children.
  • * This study assesses HAV seroprevalence in young children in India to inform immunization strategies.

Purpose of the Study:

  • * To determine the seroprevalence of Hepatitis A virus (HAV) IgG antibodies among children under five years of age in Northern India.
  • * To evaluate the association between HAV seropositivity and demographic/environmental factors.
  • * To assess the need for universal HAV immunization in this age group.

Main Methods:

  • * A cross-sectional study involving 1084 healthy children aged 1-5 years was conducted in Northern India from April 2014 to July 2015.
  • * Serum IgG against HAV was analyzed using the enzyme-linked immunosorbent assay (ELISA) method.
  • * Sample size was determined based on an estimated 40% HAV seropositivity and a 5% alpha error.

Main Results:

  • * Overall HAV IgG seroprevalence was 43.5% among the 1084 enrolled children.
  • * Seroprevalence was significantly lower in younger children (12-23 months) (OR=0.73, p=0.03).
  • * Lower seropositivity was observed in boys, and families with safe drinking water and improved sanitation.

Conclusions:

  • * Younger children (<5 years) exhibit lower HAV seropositivity, increasing their susceptibility to infection.
  • * Risk factors for lower seropositivity include younger age, unsafe water, poor sanitation, and lower parental education.
  • * Optional vaccination at one year, alongside public health initiatives for water, hygiene, and food safety, is recommended.
Abstract

Related Concept Videos

Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
630
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.4K
Changes in the Appendicular Skeleton with Age01:09

Changes in the Appendicular Skeleton with Age

The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
3.4K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
191
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
230
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
234